Chinese Academy of Medical Sciences, Fuwai Hospital: Hypertension trials

The registry lists 18 Hypertension studies with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Early Phase 1 2Phase 1 1Phase 2 1Phase 4 2No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Covered vs Bare Metal Stents for Atherosclerotic Renal Artery StenosisNot yet recruitingNCT07566065Not applicable
• Multimodal Cardiovascular Magnetic Resonance Imaging for Cardiometabolic Pre-HF and HFpEFEnrolling by invitationNCT07336316
• Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic HyperaldosteronismRecruitingNCT07328230Not applicable
• Study of Early Pharmaceutical Intervention for Cardiovascular Disease Prevention in Stage 1 HypertensionNot yet recruitingNCT05564780Not applicable
• Effect of Intensive FMT on Primary HypertensionStatus unknownNCT05608447Phase 1
• Effect of Probiotics on Primary HypertensionCompletedNCT05095350Early Phase 1
• Effect of Gut Microbiome Restoration on Primary Hypertension Via FMTStatus unknownNCT04406129Early Phase 1
• Effect of Gut Microbiome Restoration on Primary Hypertension Via Dietary InterventionCompletedNCT04403347Not applicable
• Hypertension Registry of "Hypertension Prevention and Control Initiative in China"Status unknownNCT04289701
• Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Hypertension in ChinaStatus unknownNCT03185572
• The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPDStatus unknownNCT03185364Not applicable
• Genetic Testing of Monogenic Hypertension in Chinese PopulationStatus unknownNCT03012295
• Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive PatientsStatus unknownNCT02254824Phase 4
• Registry for Pulmonary Hypertension Due to Left Heart Disease in ChinaStatus unknownNCT02164526
• The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the PrognosisStatus unknownNCT01703780
• Registry for Pulmonary Hypertension in ChinaStatus unknownNCT01417338
• Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive PatientsStatus unknownNCT01011660Phase 4
• Atorvastatin in Pulmonary HypertensionCompletedNCT00615823Phase 2